Last --
Change Today 0.00 / 0.00%
Volume 0.0
4583 On Other Exchanges
Symbol
Exchange
4583 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

chiome bioscience inc (4583) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHIOME BIOSCIENCE INC (4583)

Related News

No related news articles were found.

chiome bioscience inc (4583) Related Businessweek News

No Related Businessweek News Found

chiome bioscience inc (4583) Details

Chiome Bioscience Inc. researches, develops, and supports drug discovery platform technology in Japan and internationally. It facilitates drug discovery companies, such as drug manufacturers and biotech companies to develop antibody drugs through programs based on the autonomously diversifying library system (ADLib system). The ADLib system is a monoclonal antibody generating system that provides various arrays of antibodies in vitro, without using immunization. The company deploys the ADLib system to generate antibodies for the development of therapeutics candidates; and licenses the ADLib system to pharmaceutical and diagnostic companies. Chiome Bioscience Inc. was founded in 2005 and is headquartered in Tokyo, Japan.

Founded in 2005

chiome bioscience inc (4583) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chiome bioscience inc (4583) Key Developments

Chiome Bioscience Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2014; Provides Consolidated and Non-Consolidated Earnings Guidance for the Year Ending December 31, 2014

Chiome Bioscience Inc. announced consolidated and non-consolidated earnings results for the year ended March 31, 2014. For the year, the consolidated company reported net sales of ¥434 million, operating loss of ¥708 million, ordinary loss of ¥706 million or net loss of ¥757 million or ¥39.62 loss per share. Return on equity negative to 27.6% and ordinary income to total assets negative to 22.4%. Cash flow used in operating activities of ¥552 million. Loss before income taxes was ¥743.37 million. Net cash used in operating activities of ¥552.42 million, purchase of property, plant and equipment of ¥274.553 million and purchase of intangible assets of ¥4.69 million. For the year, the non-consolidated company reported net sales of ¥412 million, operating loss of ¥690 million, ordinary loss of ¥692 million or net loss of ¥748 million or ¥39.12 loss per share compared to net sales of ¥324 million, operating loss of ¥413 million, ordinary loss of ¥424 million or net loss of ¥426 million or ¥25.48 loss per share a year ago. The consolidated company expected net sales of ¥342 million, operating loss of ¥1,043 million, ordinary loss of ¥1,041 million, net loss of ¥1,043 million or ¥54.56 loss per share for the fiscal year ending December 31, 2014. The non-consolidated company expected net sales of ¥206 million, operating loss of ¥1,045 million, ordinary loss of ¥1,043 million, net loss of ¥1,044 million or ¥5.46 loss per share for the fiscal year ending December 31, 2014.

Chiome Bioscience Inc., Annual General Meeting, Jun 24, 2014

Chiome Bioscience Inc., Annual General Meeting, Jun 24, 2014. Agenda: To consider amendment to a portion of the company's Articles of Incorporation to change its account settlement date from March 31 to December 31 from fiscal 2014.

Chiome Bioscience Inc., 2014 Earnings Call, May 15, 2014

Chiome Bioscience Inc., 2014 Earnings Call, May 15, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4583:JP ¥1,391.00 JPY -12.00

4583 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4583.
View Industry Companies
 

Industry Analysis

4583

Industry Average

Valuation 4583 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 65.3x
Price/Book 6.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 56.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHIOME BIOSCIENCE INC, please visit www.chiome.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.